Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinically silent pheochromocytoma presenting as an adrenal incidentaloma: the importance of biochemical evaluation.

Created on 12 Sep 2026

Authors

Saraswathi Saiprasad, Narayana Swamy

Published in

BMJ case reports. Volume 19. Issue 9. Sep 11, 2026. Epub Sep 11, 2026.

Abstract

Pheochromocytoma is an uncommon catecholamine-secreting tumour that may rarely present without classic adrenergic symptoms. We report a woman in her late 70s with an incidentally detected 5 cm left adrenal mass identified during imaging for unrelated indications. Despite long-standing, well-controlled hypertension and absence of classic catecholamine excess symptoms, biochemical evaluation revealed elevated plasma free metanephrines, confirming pheochromocytoma. A CT scan demonstrated a predominantly cystic adrenal lesion with minimal enhancement; however, elevated unenhanced attenuation values were atypical for a benign adrenal adenoma and warranted biochemical evaluation to exclude a hormonally active adrenal lesion. Minimally invasive surgical management was pursued because untreated pheochromocytoma may result in cardiovascular and perioperative complications even in clinically asymptomatic individuals. Surgical resection achieved biochemical cure. This case highlights the importance of biochemical evaluation of adrenal incidentalomas, particularly in elderly patients without classic adrenergic symptoms.

PMID:
42728076
Bibliographic data and abstract were imported from PubMed on 12 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement